Immedica Pharma today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of Loargys® (pegzilarginase-nbln), an arginine specific enzyme indicated for the ...
When bacteria in the mouth break down sugars from food, they release acids that gradually erode tooth enamel and cause cavities. These bacteria do not live alone. They form dense, ...
LOARGYS is the first and only therapy proven to lower arginine in patients 2 years of age and older living with ARG1-D -- ARG1-D is an ultra-rare, debilitating, and progressive metabolic disease ...
Phase 3 PEACE trial data support the accelerated approval of Loargys for the treatment of arginase 1 deficiency in pediatric and adult patients.
MedPage Today on MSN
FDA Approves Desmoda for Central Diabetes Insipidus
Liquid alternative to desmopressin tablets allows for more precise dosing ...
Four years after the FDA issued its most heavy-handed form of a rejection to the prior company behind pegzilarginase, the U.S. regulator has now given the treatment a thumbs-up. | Four years after the ...
A natural amino acid present in saliva reduces the acidity of dental plaque and could stop cavities at their source.
Revolutionary Liquid Pump Product for Optimal Performance Tempe, Aruba - February 25, 2026 / Performance Supplements / ...
By Kamal Choudhury Feb 25 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Eton Pharmaceuticals' first-of-its-kind liquid therapy for a rare hormonal disorder, offering a more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results